#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Splenic marginal zone lymphoma Leber's congenital amaurosis Progressive supranuclear palsy Cardiomyopathy Haemophilia B without inhibitors Chondrosarcoma metastatic Fibrodysplasia ossificans progressiva Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Malignant melanoma Cytokine release syndrome Spinal muscular atrophy Haemophilia A without inhibitors Uterine leiomyosarcoma Pericarditis Kearns-Sayre syndrome More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Trials in Disease Gaucher’s disease type III – Basic Information Haemophilia A without inhibitors – Basic Information Haemophilia B with anti factor IX – Trials in Disease Niemann-Pick disease – Life with Disease Gastrointestinal stromal tumour – Life with Disease Osteosarcoma metastatic – Diagnostics Osteosarcoma metastatic Lymphangioma – Basic Information Arterial tortuosity syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Peginterferon Beta-1A Thymalfasin Hydroxocobalamin Axicabtagene Ciloleucel Desonide Intestifix Taminadenant Fezolinetant Garadacimab Ublituximab Perflubutane Ambroxol Hydrochloride Efanesoctocog Alfa Apadamtase Alfa Ergocalciferol Imidapril Hydrochloride HUMAN COAGULATION FACTOR XIII Soya Oil Valaciclovir Mepacrine More therapies…

    Learn about Your Condition

    Epithelioid sarcoma Polycythaemia vera Polyneuropathy Endocarditis bacterial Hypervolaemia Penile squamous cell carcinoma Tertiary adrenal insufficiency Mite allergy Dyslipidaemia Retinoblastoma Kidney transplant rejection Antithrombin III deficiency Vascular graft thrombosis Bile acid synthesis disorder Ventricular extrasystoles More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study Comparing Amitriptyline, Flunarizine, Topiramate, and Propranolol for Preventing Migraines in Primary Care Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Phentermine
    • Propranolol Hydrochloride
    • Topiramate
    Spain

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study of acetylsalicylic acid to prevent stroke in patients undergoing brain aneurysm coiling procedure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Lactose Monohydrate
    • Acetylsalicylic Acid
    France

  • Study comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.

    Recruiting

    3 1 1
    Investigated Diseases:
    • Retinal artery occlusion
    Investigated Drugs:
    • Sodium Chloride
    • Acetylsalicylic Acid
    • Tenecteplase
    Belgium Denmark Finland Ireland Norway Sweden

  • Study on the Effects of Dornase Alfa for Patients with Subarachnoid Hemorrhage to Improve Independence After 6 Months

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aneurysm ruptured
    Investigated Drugs:
    • Dornase Alfa
    France

  • Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Caffeine
    France
Previous Page
1 … 35 36 37 38 39 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!